Transpire Bio announced today that its Chief Executive Officer, Dr. Xian-Ming Zeng, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 15, 2026 at ...

Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced that it has successfully dosed the ...

WESTON, Fla., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Transpire Bio, an integrated, clinical-stage biopharmaceutical company focused on developing inhaled medicines, today announced the company dosed the ...

Transpire Bio, an integrated, clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced that the U.S. FDA has completed a ...

WEST PALM BEACH, Fla. — June 1 marks the start of Pride month. People can expect to see parades, festivals, and concerts to celebrate the LGBTQ+ community. As we celebrate Pride Month, we’re ...

SUNRISE, Fla., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, ...

Transpire Bio has tapped Recipharm to support the development of its inhaled respiratory disease drug candidates. The agreement positions Transpire to tap into Recipharm’s experience of developing and ...

NEW YORK--(BUSINESS WIRE)--CI&T (NYSE: CINT), a global digital specialist, announces today, as a complement to the market announcement of August 16, 2022, the completion of the acquisition of ...

Melbourne-based technology consultancy Transpire is to cease trading as of 9 December following its September acquisition and will merge into parent company CI&T’s Australian office. By integrating ...

Brasilian-headquartered digital giant CI&T has acquired Melbourne-based technology consultancy Transpire for $23.4 million as part of its Asia Pacific (APAC) growth ambitions. Headquartered in ...